MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Read more about MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Read more about Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia.
Early mixed chimerism-based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia. Read more about Early mixed chimerism-based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia.
Stereotactic body radiotherapy for pediatric hepatocellular carcinoma with central biliary obstruction. Read more about Stereotactic body radiotherapy for pediatric hepatocellular carcinoma with central biliary obstruction.
A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials. Read more about A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy? Read more about Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
Severe, persistent, and fatal T-cell immunodeficiency following therapy for infantile leukemia. Read more about Severe, persistent, and fatal T-cell immunodeficiency following therapy for infantile leukemia.
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study. Read more about Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma. Read more about A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Read more about Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.
